Sponsored Links
| Avila Announces Selection Of Clinical Drug Candidate In EGFR Mutant-Selective Inhibitor Alliance With Clovis Oncology |
 |
 |
 |
| Medical News - Lung Cancer | |||
|
Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that it has achieved a significant goal in its alliance with Clovis Oncology, Inc... Read more: Lung Cancer News From Medical News Today
|